menu
    • menu

    Company profile for Innopharma Inc

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    InnoPharma, Inc. Founded in 2005, is a privately held pharmaceutical development company, based in Piscataway, New Jersey. ” InnoPharma is dedicated to developing complex generic and innovative specialty pharmaceutical drug products in a high quality, time efficient and cost effective manner. For us, providing value add to patients, prescribers and distributors is at the core of our business model. “

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Innopharma IncUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    10 Knightsbridge Rd, Piscataway Township, NJ 08854
    Telephone
    Telephone
    +1 732 885 2939
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.pfizer.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/innopharma-inc-
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Innopharma's Generic Propofol Receives Approval In US
    Innopharma's Generic Propofol Receives Approval In US

    16 Sep 2020

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205576

    FDA
    16 Sep 2020
    Share Share
    IMA Active and IMA Life at the 4th InnoPharma Conference
    IMA Active and IMA Life at the 4th InnoPharma Conference

    08 Aug 2019

    // PRESS RELEASE

    https://ima.it/pharma/innopharma-conference-2019/

    PRESS RELEASE
    08 Aug 2019
    Share Share
    Innopharma Licensing's Generic Bromfenac Sodium Receives Approval In US
    Innopharma Licensing's Generic Bromfenac Sodium Receives Approval In US

    03 Jun 2019

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203368

    FDA
    03 Jun 2019
    Share Share
    Innopharma`s Generic Bendamustine Hydrochloride Receives Tentative Approval In US
    Innopharma`s Generic Bendamustine Hydrochloride Receives Tentative Approval In US

    19 Jun 2018

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205476

    FDA
    19 Jun 2018
    Share Share
    Allergan, InnoPharma agree to terms on Restasis generic
    Allergan, InnoPharma agree to terms on Restasis generic

    13 Oct 2017

    // E. Sagonowsky FIERCE PHARMA

    http://www.fiercepharma.com/legal/allergan-pfizer-s-innopharma-agree-to-terms-restasis-generic-launch

    E. Sagonowsky FIERCE PHARMA
    13 Oct 2017
    Share Share
    After Pfizer buyout, VCs back team with $55M for next specialty pharma
    After Pfizer buyout, VCs back team with $55M for next specialty pharma

    28 Jul 2016

    // Stacy Lawrence FIERCE BIOTECH

    http://www.fiercebiotech.com/biotech/after-pfizer-buyout-vcs-back-team-55m-for-next-specialty-pharma

    Stacy Lawrence FIERCE BIOTECH
    28 Jul 2016
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search